![Edwin L. Parsley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Edwin L.
Parsley worked as Director-Global Medical Affairs at Encysive Pharmaceuticals, Inc. and Seqirus GmbH.
Served as Principal at Pfizer Inc. Held the position of Chief Medical Officer & Senior Vice President at Mast Therapeutics, Inc. Worked as Chief Medical Officer at Liquidia Technologies, Inc., Aires Pharmaceuticals, Inc., Respira Therapeutics, Inc., and Bellerophon Therapeutics, Inc. Served as Chief Medical Officer & Senior Vice President at Savara, Inc. Worked as Assistant Professor at The University of Texas at Austin.
Completed a doctorate at Oklahoma State University.
Completed undergraduate studies at Southwestern Oklahoma State University.
| Sociétés | Poste | Fin |
|---|---|---|
| SAVARA INC. | Directeur Technique/Scientifique/R&D | 27/04/2017 |
Liquidia Technologies, Inc.
 Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops particle-based vaccines and therapeutics for prevention and treatment of human disease | Directeur Technique/Scientifique/R&D | - |
Respira Therapeutics, Inc.
 Respira Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Focuses on pulmonary delivery of therapeutics for respiratory diseases | Directeur Technique/Scientifique/R&D | - |
| BELLEROPHON THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | - |
Mast Therapeutics, Inc.
 Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapies for serious or life-threatening diseases with significant unmet needs | Directeur Technique/Scientifique/R&D | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 12 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Encysive Pharmaceuticals, Inc.
 Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases | Health Technology |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapies for serious or life-threatening diseases with significant unmet needs | Health Technology |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops particle-based vaccines and therapeutics for prevention and treatment of human disease | Health Technology |
Bellerophon Therapeutics, Inc.
 Bellerophon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing and commercializing of pharmaceutical products to treat cardiopulmonary diseases | Health Technology |
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oklahoma State University
 Oklahoma State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Southwestern Oklahoma State University
 Southwestern Oklahoma State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aires Pharmaceuticals, Inc.
 Aires Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Develops drugs to treat pulmonary disorders | Health Services |
Seqirus GmbH
 Seqirus GmbH BiotechnologyHealth Technology Develops and produces flu vaccines | Health Technology |
Respira Therapeutics, Inc.
Respira Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Focuses on pulmonary delivery of therapeutics for respiratory diseases | Health Technology |
Savara, Inc.
 Savara, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals to treat respiratory diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
